US awards Moderna $590 million for bird flu vaccine development
(Reuters) -The U.S. government has awarded Moderna (NASDAQ:MRNA) $590 million to advance the development of its bird flu vaccine, as...
Read more(Reuters) -The U.S. government has awarded Moderna (NASDAQ:MRNA) $590 million to advance the development of its bird flu vaccine, as...
Read moreBy David Shepardson WASHINGTON (Reuters) -The outgoing head of the Federal Communications Commission said a massive Chinese-linked cyber-espionage operation against...
Read moreBy Jonathan Stempel NEW YORK (Reuters) – Federal prosecutors on Friday dropped their corruption case against former New York Lieutenant...
Read moreBy Manya Saini, Niket Nishant (Reuters) -A raft of U.S. banks reported higher fourth-quarter profits on Friday, extending a winning...
Read moreBy David Lawder WASHINGTON (Reuters) – The Congressional Budget Office on Friday forecast a $1.865 trillion U.S. budget deficit for...
Read moreWASHINGTON (Reuters) – The executive board of the International Monetary Fund on Friday approved the second review of Ethiopia’s current...
Read moreWASHINGTON (Reuters) – U.S. Treasury Secretary Janet Yellen said that the government would reach its statutory borrowing limit on Tuesday...
Read moreWASHINGTON (Reuters) – The U.S. on Friday imposed sanctions on a Yemen-based financial institution that Washington accused of financially supporting...
Read moreBy Doina Chiacu, Michael Martina and Yukun Zhang WASHINGTON (Reuters) -U.S. President-elect Donald Trump and Chinese President Xi Jinping discussed...
Read moreBy Tom Wilson (Reuters) – Advocates and holders of crypto will soon influence U.S. policy on the emerging technology after...
Read more